Posizioni attive di Pierre Miniou
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Inflectis Bioscience SAS
 Inflectis Bioscience SAS BiotechnologyHealth Technology Inflectis Bioscience SAS develops therapeutics for the treatment of protein misfolding diseases. The firm engages in the development of new chemical series for the treatment of non-orphan diseases whose etiology also lies in the accumulation of misfolded proteins. The company was founded in September 2013 by Philippe Guedat and Pierre Miniou and is headquartered in Nantes, France. | Direttore/Membro del Consiglio | 01/09/2013 | - |
| Direttore operativo | 01/09/2013 | - | |
| Fondatore | 01/09/2013 | - | |
| Corporate Officer/Principal | 01/09/2013 | - |
Storia della carriera di Pierre Miniou
Precedenti posizioni note di Pierre Miniou
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Vivalis SA
 Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Corporate Officer/Principal | 16/07/2010 | 28/05/2013 |
Statistiche
Distribuzione geografica
| Francia | 3 |
Posizioni
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Health Technology |
Inflectis Bioscience SAS
Inflectis Bioscience SAS BiotechnologyHealth Technology Inflectis Bioscience SAS develops therapeutics for the treatment of protein misfolding diseases. The firm engages in the development of new chemical series for the treatment of non-orphan diseases whose etiology also lies in the accumulation of misfolded proteins. The company was founded in September 2013 by Philippe Guedat and Pierre Miniou and is headquartered in Nantes, France. | Health Technology |
- Borsa valori
- Insiders
- Pierre Miniou
- Esperienza
